Search Results for 'Biogen Idec'

1 results found.

Good news for Elan as study illustrates Tysabri MS success

image preview

Athlone-based drug developer and its US partner, Biogen Idec, last evening hailed success from a study into the effects of their MS drug, Tysabri in repairing damage to the myelin sheath, a key cause of MS.

 

Page generated in 0.0351 seconds.